Skip to main content

Table 5 Multivariate analysis of [68Ga]Ga-DOTA-TOC PET/CT variables with ECOG performance

From: Tumour-to-liver ratio determined by [68Ga]Ga-DOTA-TOC PET/CT as a prognostic factor of lanreotide efficacy for patients with well-differentiated gastroenteropancreatic-neuroendocrine tumours

VariableMultivariate analysis IMultivariate analysis IIMultivariate analysis III
Hazard ratio (95% CI)p valueHazard ratio (95% CI)p valueHazard ratio (95% CI)p value
EGOG performance status (1 vs. 0)3.518 (0.988–12.525)0.0523.528 (1.000–12.454)0.0503.188 (0.908–11.191)0.070
Tumour-to-liver ratio (TLR) (< 8.1 vs. ≥ 8.1)3.182 (1.189–8.514)0.021*NANANANA
SUVmax (< 42.9 vs. ≥ 42.9)NANA2.493 (0.960–6.475)0.061NANA
Whole tumour volume (WTV) (≥ 58.9 cm3 vs. < 58.9 cm3)NANANANA2.294 (0.917–5.743)0.076
  1. NA not assessed
  2. *Statistically significant (p < 0.05)